Creator of innovative respiratory disease management platform closes seed round, led by Blue Cross Blue Shield of Massachusetts’ Zaffre Investments. NEW YORK, NY December 15, 2015 Cohero Health, a digital health company focused on developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has announced that they closed a seed investment round […]
Nov 30, 2015 NEW YORK (GenomeWeb) – Human Longevity said today that it has acquired genome informatics firm Cypher Genomics for an undisclosed amount. San Diego-based Cypher Genomics has been offering human genome interpretation software. The company’s 14 employees will join Human Longevity, including CEO and cofounder Ashley Van Zeeland, who is now heading Human […]
Scanadu, a health tech startup working on devices that can scan and upload medical-grade diagnostic tests to a smartphone, has raised $35 million in Series B financing. The round was led by Chinese investment firms Fosun International and Tencent Holdings Limited, with participation from China Broadband Capital and Iglobe Partners of Singapore, as well as […]
NEW YORK (GenomeWeb) – Invitae has launched its initial public offering at $16 per share. The San Francisco-based molecular diagnostics firm offered 6,350,000 shares of its common stock, bringing in gross proceeds of $101.6 million. It also has granted the underwriters a 30-day option to purchase up to an additional 952,500 shares. The offering price […]
(CNN)In 2013, an Illinois man convinced several investors to fund a revolutionary medical device, to the tune of over $25 million. He called it the “McCoy Home Health Tablet”, and promised it would instantly deliver patient data to doctors. In other words, he was pitching the legendary Tricorder from Star Trek, even naming it after […]
SAN FRANCISCO —January 9, 2015—Invitae Corporation announced today that it has filed a registration statement on Form S‐1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet […]